Webinar sob demanda
Em que consiste a radioterapia moderna para o câncer de mama?
27 maio 2021
· 20 MIN. PARA ASSISTIR
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/pedro-lara.jpg/_jcr_content/renditions/original.image_file.100.100.4,0,465,461.file/pedro-lara.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/pedro-lara.jpg/_jcr_content/renditions/original.image_file.360.360.4,0,465,461.file/pedro-lara.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/pedro-lara.jpg/_jcr_content/renditions/original.image_file.461.461.4,0,465,461.file/pedro-lara.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/pedro-lara.jpg/_jcr_content/renditions/original.image_file.461.461.4,0,465,461.file/pedro-lara.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/pedro-lara.jpg/_jcr_content/renditions/original.image_file.461.461.4,0,465,461.file/pedro-lara.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/pedro-lara.jpg/_jcr_content/renditions/original.image_file.461.461.4,0,465,461.file/pedro-lara.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/pedro-lara.jpg/_jcr_content/renditions/original.image_file.461.461.4,0,465,461.file/pedro-lara.jpg"})
Autor
Prof. Pedro Lara, MD, PhD
Professor e presidente de Radiologia, Fernando Pessoa Canarias University, chefe do Departamento de Oncologia do San Roque University Hospital, Gran Canarias, Espanha
Resumo
O Prof. Pedro Lara fala sobre a radioterapia moderna para o câncer de mama e qual é o papel especial da APBI nesse contexto de tratamento
Este webinar clínico gravado começa com uma breve visão geral sobre os principais aspectos da radioterapia total da mama (WBRT) e o importante papel da irradiação parcial acelerada da mama (APBI). Pedro Lara concentra-se especificamente na radioterapia intraoperatória (IORT), incluindo uma rápida passagem pelos resultados a longo prazo do TARGIT-A recentemente publicados. Ele também explica por que a IORT é uma boa abordagem para tratar o leito da lesão onde se encontram possíveis margens tumorais.
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg/_jcr_content/renditions/original.image_file.100.56.23,12,1892,1064.file/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg/_jcr_content/renditions/original.image_file.360.203.23,12,1892,1064.file/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg/_jcr_content/renditions/original.image_file.768.432.23,12,1892,1064.file/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg/_jcr_content/renditions/original.image_file.1024.576.23,12,1892,1064.file/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg/_jcr_content/renditions/original.image_file.1280.720.23,12,1892,1064.file/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg/_jcr_content/renditions/original.image_file.1440.810.23,12,1892,1064.file/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg/_jcr_content/renditions/original.image_file.1869.1051.23,12,1892,1064.file/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg"})
Para desbloquear, faça login
Cadastre-se no MyZEISS para ter acesso totalVídeo – Som original: EN | Legendas: nenhuma
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.100.56.79,35,1331,739.file/627-sperk-targit-a-preview.png","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.360.203.79,35,1331,739.file/627-sperk-targit-a-preview.png","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.768.432.79,35,1331,739.file/627-sperk-targit-a-preview.png","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.1024.576.79,35,1331,739.file/627-sperk-targit-a-preview.png","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.1252.704.79,35,1331,739.file/627-sperk-targit-a-preview.png","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.1252.704.79,35,1331,739.file/627-sperk-targit-a-preview.png","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.1252.704.79,35,1331,739.file/627-sperk-targit-a-preview.png"})
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original.image_file.100.56.file/preview.png","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original.image_file.360.203.file/preview.png","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original./preview.png","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original./preview.png","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original./preview.png","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original./preview.png","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original./preview.png"})